Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials

Webinars

Flow in the Private Practice

Hear directly from Dr. Hannah Nearney and Dr. Kultar Garcha as they share their first-hand experiences with integrating Flow Neuroscience into their private practices and patient care strategies. Delving into topics such as:

  • What aspects of Flow they find most beneficial in their practice
  • Why they have chosen to incorporate Flow into their treatment protocols
  • Patient demographics they have successfully treated with Flow
  • Open Q&A session

This webinar offers invaluable insights into the practical applications of Flow Neuroscience, directly from those who have witnessed its impact in clinical settings. Also available here.

Contraindications and side-effects of Flow

Flow Neuroscience's Global Medical Director, Dr. Kultar Garcha, provides an update regarding Flow's contraindications, warnings, and side-effects. Watch this webinar to learn more on: Specifically:

  • tDCS side-effects from the literature and clinical trial
  • Flow side-effects from real-world data
  • What's changed with Flow's contraindications and warnings?
2024 Flow Prescribing Information update

Flow and the NHS

Flow Neuroscience's Head of Growth, Sam Lowden, alongside Flow Neuroscience's NHS Liasion Lead, Alexis Besson, provide a deep-dive into everything related to Flow and the NHS:

  • Dive into results from ongoing primary care, perinatal and CMHT pilots
  • Hear clinician and patient feedback  
  • Overview of recent NICE MIB324
  • Upcoming opportunities 
  • Open Q&A
Review the presentation

Overview of long-term usage and Flow treatment schedules

Flow Neuroscience's Clinical Lead, Hanna Silva, shares insights about Flow's stimulation schedule and long-term usage. Specifically:

  • Overview of the Flow treatment schedule
  • What does the evidence say about long-term usage of tDCS?
  • Alternative stimulation schedule recommendations
  • Open Q&A

EMPOWER trial interim results review

Hear directly from Flow Neuroscience Chief Clinical Officer and Founder, Daniel Månsson, in an exclusive webinar to learn more about Flow's recent clinical trial. Specifically:

  • Overview and summary of the initial results from the EMPOWER clinical trial 
  • Review what these results mean for your patients and your practice